powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1952764318
Christopher Littlejohn
M.D.
Hematology-Oncology
Longview,
TX
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
QUALITY · MIPS · 2024
Final MIPS score
85.1
Quality
67.5
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.43%
APM Entity
PRESCRIBING · PART D · 2024
Total Rx claims
646
Beneficiaries
—
Total drug cost
$540K
Distinct drugs
22
Brand share
39.9%
Top prescribed drugs
Apixaban
87 claims
Hydrocodone/Acetaminophen
86 claims
Letrozole
81 claims
Dexamethasone
49 claims
Prednisone
34 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
3,746
Unique beneficiaries
—
Total services
121,469
Distinct HCPCS
77
Medicare payment
$1.0M
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 613 Hematology-Oncology providers in TX — top quintile (cohort median 2,625).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$1K
Payment records
61
By payment type
Food and Beverage
$1K
Top paying entities
Food and Beverage
$1K